MITRO Biotech

About:

MITRO Biotech is the molecular imaging and pharmaceutical R&D outsourcing services.

Website: http://www.mi-tro.com/

Top Investors: Chengdu Science and Technology Innovation Investment Group, SDIC Fund Management, Yantai Guofeng Investment, State Development & Investment Corporation, Yantai Dongcheng Pharmaceutical

Description:

Mido Bio is a domestic molecular imaging medical R&D outsourcing enterprise. They provide the drug development cycle, reduce the risk of failure, and expedite the introduction of new drugs. They also provide domestic and foreign pharmaceutical companies and research institutes with overall solutions for drug development, such as drug screening, biodistribution, pharmacokinetic research, and pharmacodynamic evaluation.

Total Funding Amount:

380M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jiangning, Jiangsu, China

Founded Date:

2012-01-01

Contact Email:

info(AT)mi-tro.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-03-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai